BCL2 and Alzheimer disease: At the level of synaptic contacts, the blocking of two Ca2+ release channels from the ER is sufficient to reduce defects in AD, but at the tissue level, the positive synaptoprotective effect may be leveled by other functions of the native form of Bcl-2.